From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|Legal status||Experimental/not yet approved (US)|
|(what is this?)|
Oxotremorine produces ataxia, tremor and spasticity, similar to those symptoms seen in Parkinsonism, and has thus become a research tool in experimental studies aimed at determining more effective anti-Parkinsonian drugs.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|